For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230118:nRSR0474Na&default-theme=true
RNS Number : 0474N Plant Health Care PLC 18 January 2023
18 January 2023
PLANT HEALTH CARE plc
("Plant Health Care" or the "Company")
Board Appointments
Plant Health Care® (AIM: PHC.L), a leading provider of novel peptides for
plant protection to global agriculture markets, is pleased to announce the
appointments of Kate Coppinger and James Ede-Golightly as Non-Executive
Directors.
Kate Coppinger is an experienced Non-Executive Director with an extensive
background in investment banking and transaction execution. Having started her
career as a research analyst at CIBC World Markets, she joined Harrison
Lovegrove in 2000 and continued in her role, which focused on M&A
transactions, within Standard Chartered Bank until 2020 following its
acquisition of Harrison Lovegrove in 2007.
James Ede-Golightly has over twenty years of experience as a professional
investor and director of growth companies. His current roles include Executive
Chairman of Oxehealth and Non-Executive Director of Silence Therapeutics Plc.
He co-founded Ora Capital Partners in 2006 having been an analyst at
Commerzbank AG and Merrill Lynch Investment Managers. James previously served
as a Non-Executive Director of Plant Health Care, between June 2013 and
November 2016.
Chris Richards, Non-Executive Chairman of Plant Health Care, commented:
"We are delighted Kate has joined the Board. Her background in M&A and
regulated industries will be an asset in terms of the Company's future product
development and geographic expansion.
"In addition, it is great to welcome James back to the Company to help us
capture the growth opportunities that we have identified.
"Maintaining the right balance of skills and experience on the Board is one of
the keys to our continued progress. These appointments strengthen the Company
and we look forward to working with Kate and James as we deliver our exciting
growth proposition."
For further information, please contact:
Plant Health Care plc
Jeffrey Tweedy, Chief Executive Officer Tel: +1 919 926 1600
Jeffrey Hovey, Chief Financial Officer
Cenkos Securities plc - Nomad & Broker Tel: + (0) 131 220 9771
Neil McDonald / Pete
Lynch
SEC Newgate (Financial Communications) Tel:+44 (0)7540 10666
Robin Tozer / George Esmond Email: phc@secnewgate.co.uk
The following information regarding the appointment of Kate Coppinger and
James Ede-Golightly is required to be disclosed under Schedule 2(g) of the AIM
Rules for Companies:
Full Name: Katherine Jane Coppinger
Age: 52
Shareholding in the Company: -
Current Directorship / Partnerships: iGas Energy plc
The Barnes Fund Trustee Limited
Serica Energy plc
Previous Directorship / Partnerships: -
Full Name: James Lawrence Ede-Golightly
Age: 43
Shareholding in the Company: 625,608 ordinary shares
Current Directorship / Partnerships: Dunheved Limited
East Balkan Properties Plc
Guernsey Chamber of Commerce
Ora Global Ltd
Oxeco Limited
Oxehealth Limited
Sarossa Plc
Serendipity Capital Limited
Silent Therapeutics Plc
Previous Directorship / Partnerships: DeepMatter Group Plc
Fermain Capital Limited
Gulfsands Petroleum Plc
Ora Limited
Oxford Advanced Surfaces Ltd
Quoram Limited (previously Quoram Plc)
There are no further disclosures to be made under Schedule 2(g) of the AIM
Rules for Companies.
About Plant Health Care plc
Plant Health Care offers products to improve the health, vigour and yield of
major field crops such as corn, soybeans, potatoes and rice, as well as
specialty crops such as fruits and vegetables. We operate globally through
subsidiaries, distributors and supply agreements with major industry partners.
Our innovative, patent-protected biological products help growers to protect
their crops from stress and diseases, and to produce higher quality fruit and
vegetables, with a favourable environmental profile.
Find out more at www.planthealthcare.com (http://www.planthealthcare.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOADBGDBDXBDGXR